(Z)-2-(2-Aminothiazole-4-Yl)-2-(Methoxycarbonylmethoxy-Imino) Acetic Acid

Is the Z/E Ratio Maintained Throughout Multi-Kilogram Acylation Campaigns?

(Z)-2-(2-Aminothiazol-4-yl)-2-(methoxycarbonylmethoxyimino)acetic acid — CAS 115611-26-2, C₉H₁₁N₃O₅S, MW 273.27 g mol⁻¹ — functions as the methyl-ester-protected oxime side chain for oral cephalosporins where the carboxymethoxyimino pharmacophore is critical. The (Z)-configuration, set during oximation of ethyl 2-(2-aminothiazol-4-yl)-2-oxoacetate with methoxycarbonylmethoxylamine under strictly thermostatted conditions (−5 °C to 0 °C), confers the transpeptidase affinity that the (E)-rotamer lacks entirely. As a consequence, every production batch is released only when the Z/E ratio, determined by HPLC on a C₁₈ column with UV detection at 254 nm, exceeds 99.2:0.8. Maintaining that ratio beyond the analytical laboratory and through the acylation reactor cycle is a separate challenge. Photostability experiments conducted on kilogram-scale batches in a GMP pilot plant have quantified the isomerization kinetics. When a filtered wet cake was exposed to ambient fluorescent lighting (ca. 800 lux) for 6 h, the E-isomer content rose from 0.15 % area to 0.62 % area, exceeding the pharmacopoeial alert threshold. The same lot held in amber glass under nitrogen showed 0.02 % area drift over 24 h. This light-induced configurational scrambling, proceeding through a triplet diradical intermediate detectable by transient absorption spectroscopy, mandates jacket-protected, low-actinic filter-dryers and opaque polyethylene liners during packaging. Routine release data from 32 consecutive commercial lots manufactured in 5000 L glass-lined reactors showed a mean Z/E ratio of 99.72:0.28 with a relative standard deviation of 0.09 %, demonstrating that the −15 °C isolation and nitrogen-blanketed centrifugation protocol is robust.

Typical Certificate-of-Analysis Parameters for Commercial Shipments

Parameter	Specification Limit	Analytical Method
Appearance	White to off-white crystalline powder	Visual inspection
Assay (anhydrous, solvent-free basis)	≥ 99.0 %	HPLC, external standard; USP ＜621＞
Z-Isomer purity	≥ 99.0 % area	HPLC, C18, 254 nm
E-Isomer	≤ 0.5 % area	HPLC, same conditions
Loss on drying (60 °C, vacuum, 4 h)	≤ 0.3 % w/w	USP ＜731＞
Residue on ignition	≤ 0.1 % w/w	USP ＜281＞
Heavy metals (as Pb)	≤ 10 ppm	USP ＜231＞ / ＜233＞
Residual solvents: acetonitrile	≤ 410 ppm	GC-headspace; USP ＜467＞
Residual solvents: dichloromethane	≤ 600 ppm	GC-headspace; ICH Q3C
Methanol	≤ 3000 ppm	GC-headspace

Discharge from the Hastelloy C-22 filter-dryer occurs under dry nitrogen counterflow. The solid is double-bagged in anti-static LDPE liners containing silica-gel dessicant (dew-point indicator included), sealed with nylon ties, and placed into fibreboard drums. This packaging, validated at 40 °C / 75 % RH for 6 months, holds moisture uptake below 0.15 % w/w. Extended storage relies on refrigerated conditions (2–8 °C); the manufacturer’s stability program reports 0.03 % assay loss after 24 months at 5 °C with no increase in the free diacid impurity. On the plant floor, the material must be equilibrated to 20–25 °C inside the unopened liner for 12 h before weighing, otherwise condensation-driven hydrolysis at the crystal surface generates 0.1–0.3 % of (Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetic acid, a persistent frustrate impurity that poisons the subsequent activation step.

Reactivity is Dictated by Solubility: Methyl Ester Versus Free Diacid

The decision to procure the methyl ester rather than the free (Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetic acid is grounded in the solvent‑solute properties of the mixed‑anhydride activation used in cefixime diketene‑equivalent coupling. The free diacid dissolves to only 1.8 g L⁻¹ in ethyl acetate at 25 °C and 4.2 g L⁻¹ in tetrahydrofuran, forcing heterogeneous activation with ethyl chloroformate and N‑methylmorpholine that stalls at 60–70 % conversion and forms intractable emulsions. The methyl ester, by contrast, has solubilities of 112 g L⁻¹ in THF, 84 g L⁻¹ in ethyl acetate, and 27 g L⁻¹ in dichloromethane, all measured gravimetrically at 22 °C. This allows a homogeneous activation protocol at −18 °C to −12 °C using 1.02 eq of pivaloyl chloride and 1.05 eq of N‑methylmorpholine in THF, generating the mixed anhydride with >98 % yield (HPLC peak-area ratio) within 45 min. The subsequent coupling with protected 7‑amino‑3‑vinyl‑3‑cephem‑4‑carboxylic acid benzhydryl ester achieves an isolated amide yield of 87–91 % after ethyl acetate/heptane crystallization, whereas identical conditions with the free diacid rarely exceed 55 % and require column chromatography to remove unreacted starting material. The methyl ester protection also determines the final deprotection sequence. The methoxycarbonylmethyl group is cleaved hydrolytically under alkaline conditions (1.2 eq NaOH, THF/water 3:1 v/v, 0–5 °C, 2 h) without epimerisation at the C‑7 side-chain methine, confirmed by chiral HPLC on an amylose‑based column. The free diacid, if used directly, precludes chemoselective amide formation unless the carboxymethyl group is first protected in situ as a silyl ester, an additional transformation that consumes reagent and lengthens the cycle time.

Comparative Properties of Thiazole Oxime Side‑Chain Derivatives

Property	Methyl Ester (this product)	Free Diacid	N‑Trityl Methyl Ester
CAS RN	115611-26-2	86299-47-0	N/A – protected derivative
Molecular Weight (g mol⁻¹)	273.27	259.24	515.6
Solubility in THF (g L⁻¹, 22 °C)	112	4.2	31
Acylation Protocol	Pivaloyl chloride mixed anhydride, −15 °C	Heterogeneous activation; ethyl chloroformate	Pre‑formed active ester (HOBt/EDC)
Typical Coupling Yield	87–91 %	50–55 %	82–85 %
Deprotection	Alkaline hydrolysis, 0–5 °C	None required	Formic acid detritylation + alkaline ester hydrolysis
Primary Application	Cefixime, ceftibuten	Early-stage route scouting	Solution‑phase synthesis where amine must be masked
Critical Purity Marker	Z/E ratio, free diacid ≤0.5 %	Z/E ratio, loss on drying	Z/E ratio, residual triphenylmethanol

Tracking Process-Derived Impurities Through Synthesis Stages

The impurity profile of the methyl ester reflects the telescoped reaction sequence from 2‑(2‑aminothiazol‑4‑yl)‑2‑oxoacetic acid ethyl ester. The oxime formation itself is the most impurity‑generating step. When the methoxycarbonylmethoxylamine hydrochloride charge is made at a pH transient below 2.5, the oxime ether proceeds with 2–6 % of a des‑methyl by‑product, (Z)-2‑(2‑aminothiazol‑4‑yl)‑2‑(carboxymethoxyimino)acetic acid, which co‑crystallizes with the product and cannot be purged by simple recrystallization. The current manufacturer’s process controls pH through a potassium acetate/acetic acid buffer maintaining pH 4.8 ± 0.2, limiting the des‑methyl species to ≤0.15 % in the isolated ester. Another process‑specific impurity is the (Z)-oxime ethyl ester originating from incomplete saponification of the intermediate ester before N‑deprotection; it is controlled to ≤0.10 % and resolved from the product by the gradient HPLC system with a limit of quantitation (LOQ) of 0.02 %. ICH M7 hazard assessment classifies both the des‑methyl and the free diacid contaminants as Class 5 (non‑mutagenic structural alerts), though the manufacturer provides Ames test‑negative certificates from GLP‑compliant laboratories for every 10th commercial lot as part of the DMF open part file. Batch‑to‑batch mass balance data over 46 consecutive production runs shows a mean material yield of 74.2 % from the starting 2‑(2‑aminothiazol‑4‑yl)‑2‑oxoacetic acid ethyl ester, with the variance dominated by the recrystallization mother‑liquor losses. The mother liquor is routinely subjected to a secondary recovery campaign through solvent exchange to 2‑propanol, which yields a second crop of 87–92 % HPLC purity that is re‑processed and blended with the primary crop at a ratio not exceeding 15 % w/w; blending validation data confirm that the final product Z/E ratio is unchanged within method error.

When the 2-Aminothiazole Group is Left Unprotected During Activation

A deliberate choice in the design of this intermediate is the exposure of the primary thiazole amine, which in many related side‑chain esters (e.g., the N‑trityl‑protected variant) is masked to prevent competing N‑acylation. Leaving the amine free eliminates the need for acid‑catalyzed detritylation — a step that generates triphenylmethanol impurity and often requires scavenging on silica gel — and shortens the synthetic sequence by two operations in the final API manufacturing. The cost of that advantage is the potential formation of a branched‑amide impurity where the activated mixed anhydride attacks the thiazole NH₂ instead of the desired cephalosporin C‑7 amine. In the standard activation protocol using pivaloyl chloride/N‑methylmorpholine, monitoring by inline ReactIR during campaign‑scale batches shows that the 2‑aminothiazole NH₂ signal (3360 cm⁻¹) remains unchanged until the anhydride is added to the cephalosporin nucleophile, provided the temperature does not exceed −8 °C. When the reaction temperature rises above −5 °C due to inadequate jacket cooling, an IR band at 1648 cm⁻¹ appears within 30 min, corresponding to the branched thiazole amide, and the isolated yield drops by 6–8 percentage points. Process‑scale campaigns in 6300 L cryogenic reactors therefore maintain a validated setpoint of −15 °C ± 3 °C with a high‑viscosity alarm triggered if the mixed‑anhydride solution deviates beyond −10 °C. The stoichiometry of pivaloyl chloride is fixed at 1.02 ± 0.01 equivalents by mass flow controller, because at 1.05 eq the excess reagent slowly acylates the thiazole nitrogen even at −15 °C, a kinetic pathway that has been confirmed by spiking experiments and LC‑MS analysis of the isolated by‑product. Recoverability from the branched impurity is possible because the thiazole amide has a markedly lower solubility in 2‑propanol than the desired cephalosporin intermediate. A polish filtration of the crude reaction residue followed by cooling crystallization at −5 °C reduces the impurity to 0.08 % area, though this additional step is not required when the temperature and stoichiometry windows are observed. Residual levels of the methyl ester itself are monitored in the final cephalosporin drug substance manufacturing because incomplete amide formation can carry the side‑chain acid through to the final deprotection stage. USP and EP monographs for cefixime limit any individual unspecified impurity to 0.10 %, and the (Z)-2‑(2‑aminothiazol‑4‑yl)‑2‑(methoxycarbonylmethoxyimino)acetic acid peak — which appears at a relative retention time of 2.3 in the official HPLC method — is consistently required to fall below 0.05 % area in release testing. Process validation data from three API manufacturers confirm that the carrying through of the unreacted side chain is 0.01–0.03 % when the coupling extent exceeds 99.5 % conversion by in‑process HPLC, a condition routinely achieved with the homogeneous THF protocol.